1. Home
  2. CVKD vs JTAI Comparison

CVKD vs JTAI Comparison

Compare CVKD & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • JTAI
  • Stock Information
  • Founded
  • CVKD 2022
  • JTAI 2018
  • Country
  • CVKD United States
  • JTAI United States
  • Employees
  • CVKD N/A
  • JTAI N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • JTAI Blank Checks
  • Sector
  • CVKD Health Care
  • JTAI Finance
  • Exchange
  • CVKD Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • CVKD 8.2M
  • JTAI 9.0M
  • IPO Year
  • CVKD 2023
  • JTAI N/A
  • Fundamental
  • Price
  • CVKD $0.46
  • JTAI $0.35
  • Analyst Decision
  • CVKD Strong Buy
  • JTAI
  • Analyst Count
  • CVKD 2
  • JTAI 0
  • Target Price
  • CVKD $3.50
  • JTAI N/A
  • AVG Volume (30 Days)
  • CVKD 85.2K
  • JTAI 241.9K
  • Earning Date
  • CVKD 08-12-2024
  • JTAI 08-15-2024
  • Dividend Yield
  • CVKD N/A
  • JTAI N/A
  • EPS Growth
  • CVKD N/A
  • JTAI N/A
  • EPS
  • CVKD N/A
  • JTAI N/A
  • Revenue
  • CVKD N/A
  • JTAI $14,187,646.00
  • Revenue This Year
  • CVKD N/A
  • JTAI $23.77
  • Revenue Next Year
  • CVKD N/A
  • JTAI $14.43
  • P/E Ratio
  • CVKD N/A
  • JTAI N/A
  • Revenue Growth
  • CVKD N/A
  • JTAI N/A
  • 52 Week Low
  • CVKD $0.36
  • JTAI $0.25
  • 52 Week High
  • CVKD $2.17
  • JTAI $17.50
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 48.29
  • JTAI 36.21
  • Support Level
  • CVKD $0.43
  • JTAI $0.25
  • Resistance Level
  • CVKD $0.48
  • JTAI $0.37
  • Average True Range (ATR)
  • CVKD 0.03
  • JTAI 0.05
  • MACD
  • CVKD -0.00
  • JTAI 0.01
  • Stochastic Oscillator
  • CVKD 21.91
  • JTAI 39.80

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: